Samsung Biologics Co.,Ltd.
207940
Rang in aandelen
#498
Samsung Biologics Co.,Ltd., established in 2011 and headquartered in Incheon,... Samsung Biologics Co.,Ltd., established in 2011 and headquartered in Incheon, South Korea, provides contract services for biopharmaceutical products. The company's operations are divided into two main segments: Contract Manufacturing Organization (CMO) and Contract Development Organization (CDO). Its CDO services cover areas such as cell line development, optimization of upstream and downstream processes, and the formulation of analytical methods and final products. For CMO, the company offers aseptic filling, lyophilization, finishing, storage, shipping, and various associated support services. Additionally, it delivers comprehensive quality assurance, quality control, biosafety, and analytical testing. Samsung Biologics is also involved in creating and launching biosimilar drugs, alongside manufacturing mammalian cell-based antibody medications.
Aandeelprijs
$1,028.49
Marktkapitalisatie
$47.88B
Verandering (1 dag)
-3.67%
Verandering (1 jaar)
-18.37%
Land
KR
Handel Samsung Biologics Co.,Ltd. (207940)
Categorie
Healthcare
Koersgeschiedenis voor Samsung Biologics Co.,Ltd. (207940)
Hoogste slotkoers: $917.33 op 2026-10-01
Laagste slotkoers: $215.60 op 2016-11-01
Laagste slotkoers: $215.60 op 2016-11-01
Koersgeschiedenis van Samsung Biologics Co.,Ltd. van 2016 tot 2026
Jaarlijkse koersprestatie
| Jaar | Prestaties |
|---|---|
| 2026 (TTM) | -6.12% |
| 2025 | 12.74% |
| 2024 | 21.95% |
| 2023 | -14.64% |
| 2022 | -16.07% |
| 2021 | 2.83% |
| 2020 | 117.47% |
| 2019 | 6.18% |
| 2018 | -1.56% |
| 2017 | 164.22% |
| 2016 | 0.00% |
Aandelenkoers van vergelijkbare bedrijven of concurrenten
| Bedrijf | Aandelenkoers | Verandering 1jr% | Land |
|---|---|---|---|
| $536.13 | 25.72% |
US
|
|
| $200.12 | 645.31% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $291.76 | 2.51% |
BE
|
|
| $880.01 | 8.09% |
NL
|
